Introduction
Implementation of the EU Physical Agents (vibration) Directive in 2005 will impose appropriate health surveillance for hand -arm vibration syndrome (HAVS) on workers at exposure levels above 2.5 m/s 2 A(8) (frequency weighted, triaxial measurement). Therefore, there is a need to define a tiered strategy, initially using simple workplace screening questionnaires that will identify those workers needing follow-up by medical interview, physical examination and quantitative testing. While many variants of similar screening questionnaires are currently used, there is a lack of published evidence defining the diagnostic power of responses to specific questions in identifying the components of HAVS [1] . We attempted to establish the diagnostic power of key questions and their combination to form a screening questionnaire.
Methods
The study was undertaken by analysis of responses to questions used within the medical interview of the HAVS assessment undertaken at the Health and Safety Laboratory. The assessment was largely based on the UK Department of Trade and Industry miners' compensation scheme assessments [2] , and Health and Safety Executive Guidance [3] involving a standardized symptomatology and medical history questionnaire and quantitative testing. Referrals were diagnosed and staged by the clinician on all available information using the modified Stockholm Workshop scale [2] . This was assumed to represent the 'true' staging for the individual.
Three hundred and sixty-five of the 846 individuals attending the HAVS referral centre from November 1999 to August 2003 consented to use of their data. None was considered to have primary Raynaud's disease.
Results
The study population mean age was 45 years (SD ¼ 9, range 21 -64) and the mean length of vibration exposure was 22 years (SD ¼ 10, range 1 -43). Fifteen per cent did not have HAVS but of these, approximately 42% had suspected carpal tunnel syndrome. Twenty-nine per cent had sensorineural HAVS only either on the dominant or non-dominant hand. Three per cent had vascular HAVS only and 53% had sensorineural and vascular HAVS. Thirty per cent of those individuals with HAVS also had the criteria for suspected CTS.
Cross-tabulation with a Mantel -Haenszel Common Odds Ratio estimate was undertaken for each of the simple questions used in our questionnaire against the presence or absence of HAVS (Table 1) . Regression analysis was undertaken using the statistically significant questions identified in Table 1 . The sensorineural questions 'Do you suffer from numbness in response to the cold?', 'Do you suffer from tingling in response to the cold?', 'Do you suffer from tingling (for longer than 20 min) after using vibratory tools?' and 'Do you suffer from numbness (for longer than 20 min) after using vibratory tools?' were included in the model that had a sensitivity of 94%, specificity of 52%, with 86% of the cohort correctly assigned. The question 'Are you experiencing any stiffness with the muscles and joints of your hands or arms?' was excluded from the final model as, although it increased the specificity of the model to 59%, it reduced the sensitivity to 92%. This sensitivity and specificity would reflect positive and negative predictive values of 22 and 99% for a vibration-exposed population with a 10% prevalence of HAVS. These values are calculated on a single application of the questionnaire. In practice, such a questionnaire would be used on a regular basis. Used as a screening tool, this would lead to approximately four times the number of non-HAVS as HAVS cases being referred for further investigation. These findings are consistent with the confounding effects of a high incidence of neurosensory symptoms (such as tingling, numbness in the upper limbs), selfreported by the general population [4] ; however, the screening questionnaire would identify most of the neurosensory cases who require further examination. This analysis was also repeated for the vascular component. The questions 'Have you ever suffered with your fingers going white on exposure to cold?' and 'Do you suffer from numbness during attack of whiteness?' provided a sensitivity of 98%, specificity of 88% with 94% of the cohort correctly assigned. The inclusion of the other statistically significant questions did not increase the sensitivity and specificity of the model. There were no primary Raynaud's cases in the cohort, but these two questions would be likely to include primary Raynaud's cases within the definition of vascular HAVS. The sensitivity and specificity from these questions would reflect a positive and negative predictive value of 47% and . 99%. Therefore, if these two questions were used as the screening tool, approximately equal numbers of non-HAVS and HAVS cases would be referred for further investigation.
Our conclusions are drawn from within a physician-led assessment, with the inherent problems of non-independence between responses to these questions and to the final diagnosis. This may be particularly true for the vascular component of HAVS, where the worker's initial definition of suffering finger whiteness or blanching on cold exposure, may be modified by the physician's involvement. The data presented help to fill an identified gap in the HAVS literature. However, the use of the questions as a self-administered tool may need to be confirmed, and the value of pictures or descriptions of symptoms to accompany such questions should be investigated.
